Xilio Therapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Xilio Therapeutics, Inc.
CIK #0001840233
EDGAR Form CIK 2011 - 2025
10-K [0001840233]
10-Q [0001840233]
3 [0001840233]
4 [0001840233]
8-K [0001840233]
D [0001840233]
SC 13D [0001840233]
SC 13G [0001840233]
Form 13D/13G Filer Form 13D/13G Subject Filed
Point72 Asset Management LP Xilio Therapeutics Inc [2025-06-17]
Frazier Life Sciences Public Fund LP Xilio Therapeutics Inc [2025-06-12]
AbbVie Inc Xilio Therapeutics Inc [2025-02-18]
GKCC LLC Xilio Therapeutics Inc [2024-09-27]
Gilead Sciences Inc Xilio Therapeutics Inc [2024-04-05]
Rock Springs Capital Management LP Xilio Therapeutics Inc [2024-02-14]
MRL Ventures Fund LLC Xilio Therapeutics Inc [2023-04-10]
Octagon Capital Advisors LP Xilio Therapeutics Inc [2023-01-25]
Takeda Pharmaceutical Co Ltd Xilio Therapeutics Inc [2022-01-14]
Atlas Venture Fund Xi LP Xilio Therapeutics Inc [2021-11-05]
View All
Form 3/4/5 Subject 2011 - 2025
Russo Rene
Xilio Therapeutics, Inc.
Shannon James Samuel
Curran Daniel J.
Bonstein Sara
Brennan Aoife
Ross Robert W
Xu Yuan
Rossi Christina
Clancy Paul J
View All
Terms | Privacy | Guide
tony@aum13f.com